FDA makes some strides in eas­ing US can­cer drug sup­ply short­ages by work­ing with man­u­fac­tur­ers

The FDA has boost­ed its col­lab­o­ra­tion chan­nels with can­cer drug man­u­fac­tur­ers and health­care providers to im­prove the US sup­ply of cis­platin, car­bo­platin and methotrex­ate, ac­cord­ing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER